NCT03885245View on ClinicalTrials.gov

Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

June 30, 2026

Conditions
AsthmaObesity
Interventions
DRUG

L-ctirulline

7 weeks of treatment with 15 g/day of orally administered (powder form mixed with water) L-citrulline

DRUG

Matching Placebo

7 weeks of treatment with orally administered matching placebo (to 15 g/day of L-citrulline)

Trial Locations (1)

27705

RECRUITING

Duke University (Asthma, Allergy and Airway Center), Durham

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Duke University

OTHER

lead

University of Colorado, Denver

OTHER

NCT03885245 - Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes | Biotech Hunter | Biotech Hunter